Sangamo Therapeutics
SGMO
#8725
Rank
โ‚น14.99 B
Marketcap
โ‚น44.55
Share price
-6.45%
Change (1 day)
-73.30%
Change (1 year)

Sangamo Therapeutics (SGMO) - Total assets

Total assets on the balance sheet as of September 2025 : โ‚น7.96 Billion

According to Sangamo Therapeutics 's latest financial reports the company's total assets are โ‚น7.96 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Sangamo Therapeutics - Total assets on balance sheet (from 2001 to 2025)

Total assets by year

Year Total assets Change
2024-12-31โ‚น8.71 B-36.65%
2023-12-31โ‚น13.76 B-70.43%
2022-12-31โ‚น46.54 B-13.37%
2021-12-31โ‚น53.73 B-21.72%
2020-12-31โ‚น68.63 B50.98%
2019-12-31โ‚น45.46 B10.13%
2018-12-31โ‚น41.28 B125.48%
2017-12-31โ‚น18.30 B70.64%
2016-12-31โ‚น10.72 B-25.68%
2015-12-31โ‚น14.43 B-6.34%
2014-12-31โ‚น15.41 B77.16%
2013-12-31โ‚น8.70 B92.54%
2012-12-31โ‚น4.51 B-2.19%
2011-12-31โ‚น4.62 B63.66%
2010-12-31โ‚น2.82 B-30.42%
2009-12-31โ‚น4.05 B24.41%
2008-12-31โ‚น3.26 B-0.96%
2007-12-31โ‚น3.29 B33.28%
2006-12-31โ‚น2.47 B12.08%
2005-12-31โ‚น2.20 B46.57%
2004-12-31โ‚น1.50 B-28.56%
2003-12-31โ‚น2.10 B-21.93%
2002-12-31โ‚น2.69 B-34.27%
2001-12-31โ‚น4.10 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
โ‚น5.258 T 65,932.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น435.85 B 5,373.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚น8.097 T 101,589.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚น2.623 T 32,849.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
โ‚น5.479 T 68,704.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น17.321 T 217,419.71%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น684.09 B 8,490.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น11.637 T 146,043.52%๐Ÿ‡บ๐Ÿ‡ธ USA